Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
16.33
+1.60 (10.86%)
At close: Aug 14, 2026, 4:00 PM EDT
16.87
+0.54 (3.28%)
After-hours: Aug 14, 2026, 7:37 PM EDT
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $937.93 million as of August 14, 2026. Its market cap has increased by 749.15% in one year.
Market Cap
937.93M
Enterprise Value
700.03M
1-Year Change
749.15%
Ranking
Category
Stock Price
$16.33
ChartMarket Cap Chart
Since August 10, 2021, Climb Bio's market cap has increased from $403.20M to $937.93M, an increase of 132.62%. That is a compound annual growth rate of 18.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 937.93M | 391.12% |
| Dec 31, 2025 | 190.98M | 57.83% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
| Aug 10, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annexon | 1.00B |
| Odyssey Therapeutics | 993.35M |
| Solid Biosciences | 986.47M |
| Janux Therapeutics | 985.52M |
| Kura Oncology | 966.11M |
| Geron | 944.44M |
| Olema Pharmaceuticals | 930.10M |
| Design Therapeutics | 928.09M |